BeyondSpring (BYSI) Current Leases (2019 - 2026)
BeyondSpring's (BYSI) quarterly Current Leases came in at $171000.0 in Q2 2026, down 44.3% year-over-year from $307000.0 in Q2 2025, and down 30.49% quarter-over-quarter from $246000.0 in Q1 2026.
Powered by 
Analysis
BeyondSpring (BYSI) Current Leases (2019 - 2026) Analysis & Trends
BeyondSpring has disclosed Current Leases across 8 years of filings, most recently posting $171000.0 for Q2 2026.
- In Q2 2026, Current Leases fell 44.3% year-over-year to $171000.0; the TTM figure through Jun 2026 stood at $171000.0 (down 44.3% YoY), while the FY2025 annual figure was $320000.0, up 13.48% from the prior year.
- Current Leases came in at $171000.0 for Q2 2026 at BeyondSpring, down from $246000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $966000.0 in Q4 2022 to a low of $171000.0 in Q2 2026.
- Average Current Leases over 5 years is $451250.0, with a median of $310000.0 recorded in 2025.
- Year-over-year, Current Leases jumped 79.55% in 2022 and sank 73.29% in 2023.
- Over 5 years, Current Leases stood at $966000.0 in 2022, then slumped by 73.29% to $258000.0 in 2023, then increased by 9.3% to $282000.0 in 2024, then grew by 13.48% to $320000.0 in 2025, then plunged by 46.56% to $171000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $171000.0 in Q2 2026, $246000.0 in Q1 2026, and $320000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | - |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 263.86 Mn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 16.75 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 4.26 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | 171,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 171,000.00 |
| Mar 31, 2026 | 246,000.00 |
| Dec 31, 2025 | 320,000.00 |
| Sep 30, 2025 | 313,000.00 |
| Jun 30, 2025 | 307,000.00 |
| Mar 31, 2025 | 301,000.00 |
| Dec 31, 2024 | 282,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Dec 31, 2023 | 258,000.00 |
| Jun 30, 2023 | 784,000.00 |
| Dec 31, 2022 | 966,000.00 |
| Jun 30, 2022 | 811,000.00 |
| Dec 31, 2021 | 538,000.00 |
| Sep 30, 2021 | 390,000.00 |
| Jun 30, 2021 | 486,000.00 |
| Mar 31, 2021 | 505,000.00 |
| Dec 31, 2020 | 787,000.00 |
| Sep 30, 2020 | 697,000.00 |
| Jun 30, 2020 | 649,000.00 |
| Mar 31, 2020 | 643,000.00 |